Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Clinical Epidemiology|December 12, 2022
The DIAbetes MANagement and Treatment (DIAMANT) CohortJetty A Overbeek, Karin M A Swart, Emma Y M van der Pal, et al.The Annals of Pharmacotherapy|October 8, 2017
No Evidence for an Association Between Renal Function and Serious Bleeding Events in Patients Treated With Coumarins: A Population-Based StudyEline Houben, Elisabeth Smits, Jetty A Overbeek, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 30, 2017
Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort studyMarjolein Engelkes, Jan C van Blijderveen, Jetty A Overbeek, et al.Diabetes Care|January 26, 2019
Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy RegistriesJetty A Overbeek, Myrthe P P van Herk-Sukel, Pauline A J Vissers, et al.JCO Clinical Cancer Informatics|July 1, 2024
Improving Diagnosis and Care for Patients With Sarcoma: Do Real-World General Practitioners Data and Prospective Data Collections Have a Place Next to Clinical Trials?Emily I Holthuis, Marianne J Heins, Winan J van Houdt, et al.Vaccines|January 21, 2023
Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic ReviewJesse M van den Berg, Sharon Remmelzwaal, Marieke T Blom, et al.BMC Pulmonary Medicine|May 18, 2016
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the NetherlandsThys van der Molen, Dirkje S Postma, Richard J Martin, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
The Association between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based StudyJanine P M Faessen, Dennis J A J Oerlemans, Marc R P A de Jong, et al.Allergy, Asthma & Immunology Research|January 20, 2017
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled CorticosteroidsDirkje S Postma, Richard Dekhuijzen, Thys van der Molen, et al.Pharmacoepidemiology and Drug Safety|January 2, 2021
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysisDaniel R Morales, Tatiana Macfarlane, Thomas M MacDonald, et al.Pageof 5